Cargando...
A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
Non‐alcoholic fatty liver disease is becoming a major health burden, as prevalence increases and there are no approved treatment options. Thiazolidinediones target the nuclear receptor peroxisome proliferator‐activated receptor γ (PPARγ) and have been investigated in several clinical trials for thei...
Gardado en:
| Publicado en: | Basic Clin Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850367/ https://ncbi.nlm.nih.gov/pubmed/30561132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcpt.13190 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|